Gamma-hydroxybutyric acid tolerance
and withdrawal in a rat model

by
Bania TC, Ashar T, Press G, Carey PM.
Department of Emergency Medicine,
St. Luke's-Roosevelt Hospital Center,
Columbia University,
College of Physicians and Surgeons,
New York, NY, USA.
toxtod@aol.com
Psychopharmacology (Berl). 2002 Jul;162(3):232-8.


ABSTRACT

Long-term daily use of gamma-hydroxybutyrate (GHB) and related compounds has recently been associated with a withdrawal syndrome. To the best of the authors' knowledge, there are currently no animal models of GHB withdrawal. OBJECTIVES: The authors studied and described the effect of chronic dosing of GHB (3-6 days) on tolerance and withdrawal in a rat model. METHODS: Rats were administered GHB every three hours via intraperitoneal catheter. Groups of rats (2 per group) were dosed with GHB for either 3 (24 doses), 4 (32 doses), 5 (40 doses), or 6 (48 doses) days. The GHB dose was 0.25 g/kg for doses 1-8, 0.75 g/kg for doses 9-12, 1 g/kg for doses 13-16, 1.25 g/kg for doses 17-24, 1.5 g/kg for doses 25-32, 1.75 g/kg for doses 33-40, and 2 g/kg for doses 41-48. Following the last dose of GHB, the rats were scored using a 16-point ethanol intoxication-withdrawal scale rating spontaneous behaviors, response to handling, grooming, and neurological signs. Lower scores indicate intoxication, while higher scores indicate withdrawal. Scores were recorded at hours 0, 1, 2, 3, 4, 5, 6, 9, 12, and 24. RESULTS: Tolerance: Rats dosed with GHB for more days were less intoxicated one hour after their last GHB dose despite receiving higher doses. WITHDRAWAL: The scores for all rats dosed with GHB increased at hours 4 (p = 0.028), 5 (p = 0.037), 6 (p = 0.007), and 9 (p = 0.024) after the last dose, indicating withdrawal. The scores demonstrated a linear increase dependent upon the number of days of GHB dosing at hours 3 (p < 0.000), 4 (p = 0.004), 5 (p = 0.002), and 12 (p = 0.039) as well as prior to the last dose at hour 0 (p = 0.000). No rats developed seizures. CONCLUSIONS: Tolerance and mild withdrawal in rats can be induced by administering intraperitoneal GHB every three hours for 3-6 days. More prolonged dosing and higher doses of GHB may be necessary to induce severe withdrawal.
GHB
GABA
MDMA
Opioids
Reward
Alcohol
Dopamine
21st century
GHB and GABA
GHB withdrawal
GHB and cocaine
Drugs and reward
GHB and alcoholism
GHB and narcolepsy
Rodent polydrug abusers
GHB and growth hormone
GHB, GABA(A) and GABA(B)
GHB , tryptophan and serotonin
Drink, drugs and sex in antiquity
GHB: use, abuse and withdrawal
The first authentic antidepressant?
GHB as a signalling molecule in brain
Xyrem (sodium oxybate/GHB): prescribing information (PDF)
Presence of GHB and GBL in alcoholic and non-alcoholic drinks


Refs
and further reading

HOME
HedWeb
Nootropics
Cocaine.org
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family